Pharma Industry News

Influential Celgene Chairman Bob Hugin says goodbye amid talk of a New Jersey Senate run

Written by David Miller

Celgene Chairman Bob Hugin handed the CEO baton to Mark Alles in 2016, but he retained serious influence at the company—and in the biotech industry overall. Now, he's bidding goodbye to the company he joined 19 years ago. Up next? Maybe a run for the Senate.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]